Biopharmaceutical Excipients Market Size, Share, Growth Analysis, Forecast Report 2024-2032

Biopharmaceutical Excipients Market

Biopharmaceutical Excipients Market By Products (Specialty Excipients, Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Others), By Function (lubricants & glidants, Preservatives, Disintegrants, Coatings, Binders, Pharmaceutical Fillers, and Others), By Application (Advanced Delivery System, Parenteral, Topical, and Oral): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032-

Category: Chemical & Materials Report Format : PDF Pages: 130 Report Code: ZMR-5639 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.68 Billion USD 4.81 Billion 6.7% 2023

Biopharmaceutical Excipients Market

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Products
        • 2.1.1.2. Market Attractiveness Analysis, By Function
        • 2.1.1.3. Market Attractiveness Analysis, By Application
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Biopharmaceutical Excipients Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Biopharmaceutical Excipients Market – Products Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Products, 2020 & 2028
    • 4.2. Specialty Excipients
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Carbohydrates
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Pulyuls
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Sulubilizers & Surfactants/Emulsifiers
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Others
      • 4.6.1. Market Size and Forecast, By Region (USD Million)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Biopharmaceutical Excipients Market – Function Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Function, 2020 & 2028
    • 5.2. lubricants & glidants
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Preservatives
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Disintegrants
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Coatings
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Binders
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Pharmaceutical Fillers
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Others
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6: Biopharmaceutical Excipients Market – Application Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 6.2. Advanced Delivery System
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Parenteral
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Topical
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Oral
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7: Biopharmaceutical Excipients Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Products, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Function, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Products, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Function, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Application, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Products, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Function, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Application, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Products, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Function, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Application, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Products, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Function, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Products, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Function, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Application, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Products, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Function, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Application, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Products, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Function, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Application, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Products, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Function, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Application, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Products, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Function, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Application, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Products, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Function, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Products, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Function, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Products, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Function, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Application, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Products, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Function, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Application, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Products, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Function, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Application, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Products, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Function, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Application, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Products, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Function, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Products, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Function, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Products, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Function, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Products, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Function, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Application, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Products, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Function, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Application, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Products, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Function, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Products, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Function, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Products, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Function, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Products, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Function, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Products, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Function, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 8: Biopharmaceutical Excipients Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9: Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Biopharmaceutical Excipients Market: Company Market Share, 2019
      • 9.1.2. Global Biopharmaceutical Excipients Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Biopharmaceutical Excipients Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Biopharmaceutical Excipients Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Evonik Industries AG
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. BASF SE
    • 10.3. Akzo Nobel NV
    • 10.4. DFE Pharma
    • 10.5. Clariant
    • 10.6. IMCD
    • 10.7. Ferro Corporation
    • 10.8. Roquette Frères
    • 10.9. Spectrum Chemical Manufacturing Corp.
    • 10.10. Associated British Foods
  • Chapter No. 11: Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12: Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Products
FIG NO. 2. Market Attractiveness Analysis, By Function
FIG NO. 3. Market Attractiveness Analysis, By Application
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Biopharmaceutical Excipients Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Products, 2020 & 2028
FIG NO. 8. Global Biopharmaceutical Excipients Market for Specialty Excipients, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Specialty Excipients, By Country, 2020 & 2028
FIG NO. 10. Global Biopharmaceutical Excipients Market for Carbohydrates, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Carbohydrates, By Country, 2020 & 2028
FIG NO. 12. Global Biopharmaceutical Excipients Market for Polyols, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Polyols, By Country, 2020 & 2028
FIG NO. 14. Global Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers, Revenue (USD Million) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers, By Country, 2020 & 2028
FIG NO. 16. Global Biopharmaceutical Excipients Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Others, By Country, 2020 & 2028
FIG NO. 18. Market Revenue Share, By Function, 2020 & 2028
FIG NO. 19. Global Biopharmaceutical Excipients Market for lubricants & glidants, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for lubricants & glidants, By Country, 2020 & 2028
FIG NO. 21. Global Biopharmaceutical Excipients Market for Preservatives, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Preservatives, By Country, 2020 & 2028
FIG NO. 23. Global Biopharmaceutical Excipients Market for Disintegrants, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Disintegrants, By Country, 2020 & 2028
FIG NO. 25. Global Biopharmaceutical Excipients Market for Coatings, Revenue (USD Million) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Coatings, By Country, 2020 & 2028
FIG NO. 27. Global Biopharmaceutical Excipients Market for Binders, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Binders, By Country, 2020 & 2028
FIG NO. 29. Global Biopharmaceutical Excipients Market for Pharmaceutical Fillers, Revenue (USD Million) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Pharmaceutical Fillers, By Country, 2020 & 2028
FIG NO. 31. Global Biopharmaceutical Excipients Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 32. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Others, By Country, 2020 & 2028
FIG NO. 33. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 34. Global Biopharmaceutical Excipients Market for Advanced Delivery System, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Advanced Delivery System, By Country, 2020 & 2028
FIG NO. 36. Global Biopharmaceutical Excipients Market for Parenteral, Revenue (USD Million) 2016 – 2028
FIG NO. 37. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Parenteral, By Country, 2020 & 2028
FIG NO. 38. Global Biopharmaceutical Excipients Market for Topical, Revenue (USD Million) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Topical, By Country, 2020 & 2028
FIG NO. 40. Global Biopharmaceutical Excipients Market for Oral, Revenue (USD Million) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Biopharmaceutical Excipients Market for Oral, By Country, 2020 & 2028
FIG NO. 42. Global Biopharmaceutical Excipients Market Revenue Share, By Region, 2020 & 2028
FIG NO. 43. North America Biopharmaceutical Excipients Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 44. Porter’s Five Forces Analysis for Global Biopharmaceutical Excipients Market
FIG NO. 45. PEST Analysis for Global Biopharmaceutical Excipients Market
FIG NO. 46. Pricing Analysis for Global Biopharmaceutical Excipients Market
FIG NO. 47. Value Chain Analysis for Global Biopharmaceutical Excipients Market
FIG NO. 48. Company Share Analysis, 2019
FIG NO. 49. Radar Determinant Chart, 2019
FIG NO. 50. Company Strategic Developments – Heat Map Analysis
FIG NO. 51. Evonik Industries AG Business Segment Revenue Share, 2020 (%)
FIG NO. 52. Evonik Industries AG Geographical Segment Revenue Share, 2020 (%)
FIG NO. 53. Market Channels
FIG NO. 54. Marketing Channel Development Trend
FIG NO. 55. Growth in World Gross Product, 2008-2018
FIG NO. 56. Research Methodology – Detailed View
FIG NO. 57. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Biopharmaceutical Excipients Market Snapshot
TABLE NO. 2. Quarterly Biopharmaceutical Excipients Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Biopharmaceutical Excipients Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Biopharmaceutical Excipients Market for Specialty Excipients, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Biopharmaceutical Excipients Market for Carbohydrates, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Biopharmaceutical Excipients Market for Polyols, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Biopharmaceutical Excipients Market for Solubilizers & Surfactants/Emulsifiers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Biopharmaceutical Excipients Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Biopharmaceutical Excipients Market for lubricants & glidants, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Biopharmaceutical Excipients Market for Preservatives, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Biopharmaceutical Excipients Market for Disintegrants, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Biopharmaceutical Excipients Market for Coatings, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Biopharmaceutical Excipients Market for Binders, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Biopharmaceutical Excipients Market for Pharmaceutical Fillers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Biopharmaceutical Excipients Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Biopharmaceutical Excipients Market for Advanced Delivery System, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Biopharmaceutical Excipients Market for Parenteral, by Region, 2016 – 2028 (USD Million)
TABLE NO. 20. Global Biopharmaceutical Excipients Market for Topical, by Region, 2016 – 2028 (USD Million)
TABLE NO. 21. Global Biopharmaceutical Excipients Market for Oral, by Region, 2016 – 2028 (USD Million)
TABLE NO. 22. Global Biopharmaceutical Excipients Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Biopharmaceutical Excipients Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 24. North America Biopharmaceutical Excipients Market Revenue, By Products, 2016 – 2028 (USD Million)
TABLE NO. 25. North America Biopharmaceutical Excipients Market Revenue, By Function, 2016 – 2028 (USD Million)
TABLE NO. 26. North America Biopharmaceutical Excipients Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 27. U.S. Biopharmaceutical Excipients Market Revenue, By Products, 2016 – 2028 (USD Million)
TABLE NO. 28. U.S. Biopharmaceutical Excipients Market Revenue, By Function, 2016 – 2028 (USD Million)
TABLE NO. 29. U.S. Biopharmaceutical Excipients Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 30. Canada Biopharmaceutical Excipients Market Revenue, By Products, 2016 – 2028 (USD Million)
TABLE NO. 31. Canada Biopharmaceutical Excipients Market Revenue, By Function, 2016 – 2028 (USD Million)
TABLE NO. 32. Canada Biopharmaceutical Excipients Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 33. Mexico Biopharmaceutical Excipients Market Revenue, By Products, 2016 – 2028 (USD Million)
TABLE NO. 34. Mexico Biopharmaceutical Excipients Market Revenue, By Function, 2016 – 2028 (USD Million)
TABLE NO. 35. Mexico Biopharmaceutical Excipients Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 36. Drivers for the Biopharmaceutical Excipients Market Impact Analysis
TABLE NO. 37. Restraints for the Biopharmaceutical Excipients Market Impact Analysis
TABLE NO. 38. Major Buyers of Biopharmaceutical Excipients
TABLE NO. 39. Distributors/Traders List of Biopharmaceutical Excipients
TABLE NO. 40. Global Biopharmaceutical Excipients Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 41. Global Biopharmaceutical Excipients Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 

Methodology

FrequentlyAsked Questions

Biopharmaceutical Excipients Market size is set to expand from $ 2.68 Billion in 2023

Biopharmaceutical Excipients Market size is set to expand from $ 2.68 Billion in 2023 to $ 4.81 Billion by 2032, with an CAGR of around 6.7% from 2024 to 2032.

Some of the key factors driving the global Biopharmaceutical Excipients market growth are Supreme Properties of Biopharmaceutical Excipients and Need for Improved Drug Delivery.

North America region held a substantial share of the Biopharmaceutical Excipients market in 2020. Asia Pacific is the fastest-growing area in the global biopharmaceutical excipients market. Several regions are undergoing expansion plans in order to increase manufacturing capacity and quickly scale up drug development standards. China, India, and South Korea, for example, are heavily involved in the production of biosimilars in this area.

Some of the major companies operating in the Biopharmaceutical Excipients market are Evonik Industries AG, BASF SE, Akzo Nobel NV, DFE Pharma, Clariant, IMCD, Ferro Corporation, Roquette Frères, Spectrum Chemical Manufacturing Corp., Associated British Foods, among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed